SCHEMBL24314201

SCHEMBL24314201

CCOc1ccccc1S(=O)(=O)NC(=O)c1cc2c(OC(F)F)cc(C3CC3)cc2o1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 3/20 0.39
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
TSHR P16473 1/20 0.35
RORC P51449 1/20 0.35
RAB9A P51151 2/20 0.35
GAA P10253 1/20 0.35
NPC1 O15118 1/20 0.33
MRGPRX1 Q96LB2 3/20 0.33
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
MMP2 P08253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TP53 P04637 1/20 0.33
TSPO P30536 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313753 0.88 MEN1 (0.38) MEN1KMT2ATSHRRORCGAA
SCHEMBL29588075 0.86 HIF1A (0.37) PTGER4MEN1KMT2ARORCGAA
SCHEMBL29588267 0.85 GAA (0.35) PTGER4MEN1KMT2ATSHRRORC
SCHEMBL29588225 0.85 PTGER4 (0.38) PTGER4MEN1KMT2AGAAMMP2
SCHEMBL24313769 0.85 PTGER4 (0.38) PTGER4MEN1KMT2AGAAMMP2
SCHEMBL24313906 0.84 PTGER4 (0.45) PTGER4MMP2
SCHEMBL24313965 0.81 LMNA (0.38) PTGER4MEN1KMT2ATSHRGAA
SCHEMBL24314200 0.81 MEN1 (0.35) MEN1KMT2ATSHRRAB9ANPC1
SCHEMBL24313957 0.81 HSD17B10 (0.37) PTGER4TSHRGAALMNASMN1; SMN2
SCHEMBL29587405 0.81 HSD17B10 (0.37) PTGER4TSHRGAALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-B1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BROAD INST INC (US) 2025-11-12 EP claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP claimed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed